Neoadjuvant treatment of nonfunctioning pancreatic neuroendocrine tumors with [177Lu-DOTA0,Tyr3]octreotate

Additional Metadata
Keywords	Neoadjuvant treatment, Pancreatic neuroendocrine tumor, PRRT, Surgery, [177LuDOTA0, Tyr3]octreotate
Persistent URL	doi.org/10.2967/jnumed.115.158899, hdl.handle.net/1765/91105
Journal	The Journal of Nuclear Medicine
Organisation	Department of Internal Medicine
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Vliet, E., van Eijck, C., de Krijger, R., Van Dijkum, E. J. N., Teunissen, J., Kam, B., de Herder, W., Feelders, R., Bonsing, B., Brabander, T., Krenning, E.& Kwekkeboom, D. (2015). Neoadjuvant treatment of nonfunctioning pancreatic neuroendocrine tumors with [177Lu-DOTA0,Tyr3]octreotate. The Journal of Nuclear Medicine, 56(11), 1647–1653.https://doi.org/10.2967/jnumed.115.158899

Publication